Penumbra

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. Its target markets include interventional neuroradiologists, neurosurgeons, neurologists, cardiologists, radiologists, and vascular surgeons. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Penumbra reports robust Q2 earnings, eyes growth amidst challenges

Penumbra's Q2 2024 earnings call showcased strong financial performance, operational efficiency, and a commitment to innovation and market access initiatives.
While facing challenges in revenue guidance reduction and competitive dynamics, the company's strengths in product performance and growth prospects position it well for the future.
Opportunities exist in leveraging innovation, addressing market challenges, and optimizing margins to drive sustained growth and competitiveness in the industry.

Penumbra reports strong Q3 earnings, eyes global blood clot market

Penumbra's Q3 2024 earnings call showcased robust financial performance, driven by revenue growth and margin expansion. The company's innovative technologies and regulatory milestones position it for future success in the blood clot treatment market. While facing challenges in sustaining growth and navigating market dynamics, Penumbra has opportunities to capitalize on its strengths and drive global transformation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.

RADNOR, Pa., Feb. 24, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against Penumbra, Inc. (NYSE: PEN) (“Penumbra”) on behalf of those who purchased or acquired Penumbra common stock between August 3, 2020 and December 15, 2020 , inclusive (the “Class Period”).

Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Penumbra, Inc. (PEN)

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Penumbra, Inc. ("Penumbra" or "the Company") (NYSE: PEN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Penumbra securities between August 3, 2020 and December 15, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/pen. This class action se

PEN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Penumbra, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

Penumbra, Inc. (PEN) CEO Adam Elsesser on Q4 2020 Results - Earnings Call Transcript

NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15, 2020, inclusive (the “Class Period”), of the important March 16, 2021 lead plaintiff deadline.

PEN INVESTOR ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Penumbra, Inc. Investors to Secure Counsel Before Important March 16 Deadline – PEN

Shares of Penumbra (NYSE:PEN) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 90.91% over the past year to $0.42, which beat the estimate of ($0.07).

Penumbra: Q4 Earnings Insights

RADNOR, Pa., Feb. 23, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Penumbra, Inc. ("Penumbra") on behalf of those who purchased or acquired Penumbra (NYSE: PEN) common stock between...

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Penumbra, Inc.

Los Angeles, California--(Newsfile Corp. - February 23, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. ("Penumbra" or "the Company") (NYSE: PEN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 3, 2020 and December 15, 2020, inclusive...

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Penumbra, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

SAN FRANCISCO, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Penumbra, Inc. (NYSE: PEN) investors to submit their losses now.   A securities fraud class action has been filed, and certain investors may have valuable claims.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Penumbra (PEN) Investors of Securities Fraud Lawsuit, Encourages Investors with Losses to Contact its Attorneys Now

Radnor, Pennsylvania--(Newsfile Corp. - February 22, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Penumbra, Inc. (NYSE: PEN) ("Penumbra") on behalf of those who purchased or acquired Penumbra common stock between August 3, 2020 and December 15, 2020, inclusive (the "Class Period").Deadline Reminder: Investors who purchased or acquired Penumbra common stock during the Class Period may, no...

Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Penumbra, Inc.

Penumbra (NYSE:PEN) will be releasing its next round of earnings this Tuesday, February 23. For all of the relevant information, here is your guide for Tuesday's Q4 earnings announcement.

Penumbra's Earnings Outlook

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15, 2020, inclusive (the “Class Period”).

DEADLINE NOTICE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Penumbra, Inc. – PEN

Penumbra (PEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for Penumbra (PEN) This Earnings Season?

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Penumbra To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - February 21, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Penumbra, Inc. ("Penumbra" or the "Company") (NYSE: PEN) and reminds investors of the March 16, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Penumbra stock or options between...

Penumbra Class Action Reminder

NEW YORK, Feb. 20, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15, 2020, inclusive (the "Class Period"), of the important March 16, 2021 lead plaintiff...

BREAKING NEWS: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Penumbra, Inc. Investors with Large Losses to Secure Counsel Before Important March 16 Deadline - PEN

New York, New York--(Newsfile Corp. - February 19, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15, 2020, inclusive (the "Class Period"), of the important March 16, 2021 lead plaintiff deadline.SO WHAT: If you purchased Penumbra securities during the Class Period you may be entitled to compensation without payment of any out of...

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Penumbra, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline - PEN

LOS ANGELES, Feb. 19, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. ("Penumbra" or "the Company") (NYSE: PEN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...

INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Penumbra, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Penumbra, Inc. (NYSE PEN) from August 3, 2020 through December 15, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Penumbra, Inc. investors under the federal securities laws.

Penumbra Case: Pawar Law Group Announces a Securities Class Action Lawsuit Against Penumbra, Inc.– PEN

RADNOR, Pa., Feb. 19, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against Penumbra, Inc. (NYSE: PEN) (“Penumbra”) on behalf of those who purchased or acquired Penumbra common stock between August 3, 2020 and December 15, 2020 , inclusive (the “Class Period”).

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Against Penumbra, Inc.

SAN DIEGO--(BUSINESS WIRE)-- #PENstock--The suit alleges defendants issued false statements concerning Penumbra business and prospects, resulting in its stock trading at inflated prices.

Robbins Geller Rudman & Dowd LLP Announces Lead Plaintiff Deadline in the Penumbra, Inc. Class Action Lawsuit

New York, New York--(Newsfile Corp. - February 18, 2021) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15, 2020, inclusive (the "Class Period"), of the important March 16, 2021 lead plaintiff deadline.SO WHAT: If you purchased Penumbra securities during the Class Period you may be entitled to compensation without payment of any out of...

PEN Breaking News: Rosen, National Trial Lawyers, Encourages Penumbra, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline - PEN

BERWYN, Pa., Feb. 18, 2021 /PRNewswire/ -- RM LAW, P.C. reminds investors of the upcoming March 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Penumbra Inc. ("Penumbra" or the "Company") (NYSE; PEN)...

PEN SHAREHOLDER DEADLINE: RM LAW, P.C. Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Penumbra, Inc.

RADNOR, Pa., Feb. 18, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Penumbra, Inc. (NYSE: PEN) ("Penumbra") investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Penumbra common stock...

PEN CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Penumbra, Inc. Shareholders of Securities Fraud Class Action Lawsuit

NEW YORK, Feb. 17, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...

PEN INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Penumbra, Inc.

Radnor, Pennsylvania--(Newsfile Corp. - February 17, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Penumbra, Inc. (NYSE: PEN) ("Penumbra") on behalf of those who purchased or acquired Penumbra common stock between August 3, 2020 and December 15, 2020, inclusive (the "Class Period").Deadline Reminder: Investors who purchased or acquired Penumbra common stock during the Class Period may, no...

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Penumbra, Inc.

NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15, 2020, inclusive (the “Class Period”), of the important March 16, 2021 lead plaintiff deadline.

News for Penumbra Stock (PEN)